Skip to main content
OpenTrials
Completed

NCT Number: NCT02196948

Electrolysis Percutaneous Therapeutic (EPTE) for Supraspinatus Tendinopathy

Therapeutic management of supraspinatus tendinopathy is conflicting. There is evidence that eccentric exercise protocols can be effective for this condition. The inclusion of other therapeutic modalities could help to the management of these patients. A new therapeutic approach, called Electrolysis Percutaneous Therapeutic (EPTE) has been clinically developed. The objective of this randomized clinical trial is to determine the effectiveness of the inclusion of EPTE into a eccentric exercise protocol for the management of patients with unilateral supraspinatus tendinopathy

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Supraspinatus Tendinopathy Muscular Diseases Musculoskeletal Diseases Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms Tendinopathy Tendon Injuries Wounds and Injuries

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Universidad Rey Juan Carlos

Alcorcón, Madrid, 28922, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Unilateral supraspinatus tendinopathy
  • Shoulder pain from at least 3 months
  • Shoulder pain of more than 4 points on a NPRS
  • Positive findings of supraspinatus tendinopathy on MRI

Exclusion criteria

  • bilateral shoulder symptoms
  • younger than 18 or older than 65 years
  • history of shoulder fractures or dislocation
  • cervical radiculopathy
  • previous interventions with steroid injections
  • fibromyalgia syndrome
  • previous history of shoulder or neck surgery
  • any type of intervention for the neck-shoulder area during the previous year

Treatment and study plan

Electrolysis Percutaneous Therapeutic (EPTE)

Other

Eccentric exercise

Other

Primary outcomes

  1. Changes in pain intensity before and after the intervention

    Time frame: Baseline, after 2 weeks of treatment and one week after the last session

    A 10-point Numerical Pain Rating Scale (NPRS; 0: no pain, 10: maximum pain) will be used to assess the patients' current level of shoulder pain, and the worst and lowest level of pain experienced in the preceding week in the shoulder area.

Secondary outcomes

  1. Changes in disability before and after the intervention

    Time frame: Baseline, after 2 weeks of treatment and one week after the last session

    The Disabilities of the Arm, Shoulder and Hand (DASH) will be used to determine the disability induced by shoulder pain

Sponsors and collaborators

Lead sponsor

Universidad Rey Juan Carlos

Other

Registry information

Official study title

Electrolysis Percutaneous Therapeutic (EPTE) for the Management of Supraspinatus Tendinopathy

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Jul 22, 2014
Registry last updated
Dec 3, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.